Accentia exclusive plan-filing period extended final time to Feb. 18

By Caroline Salls

Pittsburgh, Feb. 4 - Accentia Biopharmaceuticals, Inc.'s exclusive plan-filing period has been extended to Feb. 18 from Jan. 29, according to a Wednesday filing with the U.S. Bankruptcy Court for the Middle District of Florida.

According to the order, the company cannot request further extensions of the exclusive filing period beyond Feb. 18.

If a plan is filed by Feb. 18, Accentia will have the exclusive right to solicit votes on that plan through April 20.

Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10, 2008. Its Chapter 11 case number is 08-17795.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.